Oro-facial gangrene (Noma/cancrum oris): Pathogenetic mechanisms

被引:80
作者
Enwonwu, CO
Falkler, WA
Idigbe, EO
机构
[1] Univ Maryland, Sch Dent, Dept OCBS, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA
[3] Univ Maryland, Sch Dent, Dept Microbiol & Immunol, Baltimore, MD 21201 USA
[4] Nigerian Inst Med Res, Lagos, Nigeria
关键词
Noma; cancrum oris; anaerobic infection; poverty; oro-facial gangrene;
D O I
10.1177/10454411000110020201
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Cancrum oris (Noma) is a devastating infectious disease which destroys the soft and hard tissues of the oral and para-oral structures. The dehumanizing ore-facial gangrenous lesion affects predominantly children ages 2 to 16 years, particularly in sub-Saharan Africa, where the estimated frequency in some communities varies from 1 to 7 cases per 1000 population. The risk factors are poverty, malnutrition, poor oral hygiene, residential proximity to livestock in unsanitary environments, and infectious diseases, particularly measles and those due to the herpesviridae. Infections and malnutrition impair the immune system, and this is the common denominator for the occurrence of noma. Acute necrotizing gingivitis (ANG) and oral herpetic ulcers are considered the antecedent lesions, and ongoing studies suggest that the rapid progression of these precursor lesions to noma requires infection by a consortium of micro-organisms, with Fusobacterium necrophorum (Fn) and Prevotella intermedia (Pi) as the suspected key players. Additional to production of a growth-stimulating factor for Pi, Fn displays a classic endotoxin, a dermonecrotic toxin, a cytoplasmic toxin, and a hemolysin. Without appropriate treatment, the mortality rate from noma is 70-90%. Survivors suffer the two-fold afflictions of ore-facial mutilation and functional impairment, which require a time-consuming, financially prohibitive surgical reconstruction.
引用
收藏
页码:159 / 171
页数:13
相关论文
共 125 条
[1]   CANCRUM ORIS - PRINCIPLES OF MANAGEMENT AND RECONSTRUCTIVE SURGERY [J].
ADEKEYE, EO ;
ORD, RA .
JOURNAL OF MAXILLOFACIAL SURGERY, 1983, 11 (04) :160-170
[2]  
Adelsberger L., 1945, LANCET, V1, P317
[3]   Noma: A review [J].
Adolph, HP ;
Yugueros, P ;
Woods, JE .
ANNALS OF PLASTIC SURGERY, 1996, 37 (06) :657-668
[4]  
AGNEW R G, 1947, J Periodontol, V18, P22
[5]  
ALLEYNE GAO, 1977, PROTEIN ENERGY MALNU, P54
[6]   Interactions between Fusobacterium necrophorum hemolysin, erythrocytes and erythrocyte membranes [J].
Amoako, KK ;
Goto, Y ;
Misawa, N ;
DeLong, X ;
Shinjo, T .
FEMS MICROBIOLOGY LETTERS, 1997, 150 (01) :101-106
[7]  
BADERMEUNIER B, 1994, EUR J PEDIATR, V153, P339, DOI 10.1007/BF01956414
[8]  
Bakaletz Lauren O., 1995, Trends in Microbiology, V3, P110, DOI 10.1016/S0966-842X(00)88892-7
[9]  
BALOWS A, 1975, AM LECT SERIES MICRO, V940, P140
[10]   The need for action against oro-facial gangrene (noma) [J].
Barmes, DE ;
Enwonwu, CO ;
Leclercq, MH ;
Bourgeois, D ;
Falkler, WA .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (12) :1111-1114